Compositions and Methods for Treating Vascular Disorders
Tulane Case Number
TU-352
Background
Tulane is actively seeking commercial entities to further develop and commercialize our novel composition of viral vectors for impairment of pathological angiogenesis.
Applications
Anti-angiogenic therapy for treatment of age-related macular degeneration, atherosclerosis, diabetic retinopathy, and cancer.
Current Work
Proof-of-concept studies completed.
Inventors
Qinbo Zhou, PhD
Intellectual Property
Available For
Exclusive License in a Field
Non-exclusive License
Scientific Collaboration
